Winchester, MA, United States of America

Michele Sanicola-Nadel

This inventor holds 12 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignees: Biogen Idec Ma Inc., Biogen, Incorporated, The General Hospital Corporation. Active years: 2003-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michele Sanicola-Nadel. Retrieved from https://idiyas.com/inventor/michele-sanicola-nadel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 12 (Patent Applications = 4)

% Patents Active = 83.3

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 4)

Average Co-Inventor Count = 4.5

ph-index = 4

Forward Citations = 100(Granted Patents)

Company Filing History:

The General Hospital Corporation

patents

where one patent can have more than one assignee

Years Active: 2003-2014

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8673303 - Cripto blocking antibodies and uses thereof (2014-03-18),

2. 8021661 - Cripto binding molecules (2011-09-20),

3. 8003763 - Cripto blocking antibodies and uses thereof (2011-08-23),

4. 7888052 - Cripto blocking antibodies and uses thereof (2011-02-15),

5. 7674462 - Cripto blocking antibodies and uses thereof (2010-03-09),

6. 7604931 - Cripto mutant and uses thereof (2009-10-20),

7. 7582299 - Cripto-specific antibodies (2009-09-01),

8. 7531174 - Cripto blocking antibodies and uses thereof (2009-05-12),

9. 7179901 - Renal regulatory elements and methods of use thereof (2007-02-20),

10. 6861509 - Antibodies to Ret and RetL3 (2005-03-01),

11. 6677135 - Ret ligand (RetL) for stimulating neutral and renal growth (2004-01-13),

12. 6664385 - Kidney injury-related molecules (2003-12-16),

Title: The Inventive Mind of Michele Sanicola-Nadel

Introduction:

Michele Sanicola-Nadel, a prolific inventor based in Winchester, MA (US), has made significant contributions to the field of biotechnology with a total of 12 patents to his name. His groundbreaking work in developing Cripto blocking antibodies and binding molecules has opened new avenues in therapeutic interventions.

Latest Patents:

Sanicola-Nadel's latest patents showcase his innovative prowess in the realm of biotechnology. His inventions include Cripto blocking antibodies and uses thereof, enabling the modulation of Cripto signaling and tumor growth. Additionally, he has developed humanized forms of anti-CRIPTO antibodies for treating disorders like cancer, demonstrating his commitment to advancing medical treatments.

Career Highlights:

Having worked at Biogen Idec Ma Inc. and Biogen, Incorporated, Michele Sanicola-Nadel has honed his skills and expertise in the biotechnology industry. His patents reflect his dedication to pushing the boundaries of scientific discovery and improving healthcare outcomes through novel inventions.

Collaborations:

Throughout his career, Sanicola-Nadel has collaborated with esteemed professionals in the field, including coworkers like Kevin P Williams and Susan Gail Schiffer. Together, they have synergized their talents to drive innovation and develop cutting-edge solutions in biotechnology.

Conclusion:

In conclusion, Michele Sanicola-Nadel's inventive spirit and commitment to advancing biotechnology have established him as a key figure in the industry. His patents not only reflect his technical acumen but also underscore his passion for positively impacting healthcare through groundbreaking inventions. We look forward to witnessing his future contributions to the field of biotechnology.

Profile summary based on public USPTO records.